UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia

Table 2

Clinical characteristics.

Clinical characteristics	hyperlipidemia with syndrome of SLQSD	hyperlipidemia with syndrome of non-SLQSD	Healthy volunteers
n	10	19	26
Age (X±SD)	55.6±9.64	54.26±8.05	46.73±7.74
Gender [Female (%)]	60.0	63.2	53.8
TC	4.90±0.69^##	5.88±0.72	4.37±0.60
TG	2.24±0.84	2.00±1.27	1.02±0.26
HDL-C	1.17±0.31	1.40±0.33	1.37±0.27
LDL-C	2.80±0.56^##	3.55±0.75	2.50±0.48
VDL-C	0.96±0.25	0.93±0.50	0.49±0.14
ApoA1	1.36±0.30	1.44±0.19	1.40±0.18
ApoB	1.02±0. 25	1.15±0. 31	0.83±0. 16

Gender was expressed as percentage and the other data were expressed as mean ± SD. p<0.05 and p< 0.01 compared with healthy volunteer group. Hyperlipidemia with syndrome of SLQSD compared with hyperlipidemia with syndrome of non-SLQSD, ^#p<0.05, and ^##p < 0.01.